Sommaire

Numéro précédent | Numéro suivant

• • ·US cancer care: should insurers really be in the driving seat?

    Page :1

     
• • ·Rational individualised selection of adjuvant therapy for ductal carcinoma in situ

    Page :2-3

    Henry M Kuerer

     
• • ·Cetuximab in NSCLC: another trial needed

    Page :3-4

    Francesco Perrone

     
• • ·Should we screen for endometrial cancer?

    Page :4-5

    Ignace Vergote, Frédéric Amant, Dirk Timmerman

     
• • ·EPCAM deletions, Lynch syndrome, and cancer risk

    Page :5-6

    Henry T Lynch, Jane F Lynch, Carrie L Snyder, Douglas Riegert-Johnson

    
• • ·Blood-pressure drugs and cancer: much ado about nothing?

    Page :6-8

    Lars H Lindholm, Bo Carlberg

     
• • ·FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?

    Page :8-9

    Richard Kim

     
• • ·Who is in charge of assessing therapeutic drug monitoring? The case of imatinib

    Page :9-11

    Thierry Buclin, Nicolas Widmer, Jerome Biollaz, Laurent A Decosterd

     
• • ·Errata

    Page :11

    
• • ·Errata

    Page :11

    
• • ·Should anthracyclines and dexrazoxane be used for children with cancer?

    Page :12-13

    Elvira C van Dalen, Henk van den Berg, Martine F Raphaël, Huib N Caron, Leontien C Kremer

     
• • ·MET inhibitors: translating from bench to bedside

    Page :14

    Susan Mayor

    
• • ·China wrestles with lung cancer

    Page :15

    Chihua Wen, Tim Dehnel

     
• • ·NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer

    Page :16-17

    Joanne Holden, Zoe Garrett, Andrew Stevens

     
• • ·52nd ASH annual meeting

    Page :18

    Emma Grainger

    Plan Plan
• • ·33rd San Antonio Breast Cancer Symposium

    Page :19

    Tim Dehnel

    Plan Plan  
• • ·Dear Doctor

    Page :20

    Talha Burki

     
• • ·Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

    Page :21-29

    Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George

    Résumé Résumé Plan Plan   
• • ·First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

    Page :30-37

    Ulrich Gatzemeier, Joachim von Pawel, Ihor Vynnychenko, Petr Zatloukal, Filippo de Marinis, Wilfried EE Eberhardt, Luis Paz-Ares, Karl-Maria Schumacher, Thomas Goddemeier, Kenneth J O’Byrne, Robert Pirker

    Résumé Résumé Plan Plan  
• • ·Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort

    Page :38-48

    Ian Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, Ranjit Manchanda, Naveena Singh, Aarti Sharma, Andy Ryan, Mourad W Seif, Nazar N Amso, Gillian Turner, Carol Brunell, Gwendolen Fletcher, Rani Rangar, Kathy Ford, Keith Godfrey, Alberto Lopes, David Oram, Jonathan Herod, Karin Williamson, Ian Scott, Howard Jenkins, Tim Mould, Robert Woolas, John Murdoch, Stephen Dobbs, Simon Leeson, Derek Cruickshank, Steven J Skates, Lesley Fallowfield, Mahesh Parmar, Stuart Campbell, Usha Menon

    Résumé Résumé Plan Plan   
• • ·Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

    Page :49-55

    Marlies JE Kempers, Roland P Kuiper, Charlotte W Ockeloen, Pierre O Chappuis, Pierre Hutter, Nils Rahner, Hans K Schackert, Verena Steinke, Elke Holinski-Feder, Monika Morak, Matthias Kloor, Reinhard Büttner, Eugene TP Verwiel, J Han van Krieken, Iris D Nagtegaal, Monique Goossens, Rachel S van der Post, Renée C Niessen, Rolf H Sijmons, Irma Kluijt, Frans BL Hogervorst, Edward M Leter, Johan JP Gille, Cora M Aalfs, Egbert JW Redeker, Frederik J Hes, Carli MJ Tops, Bernadette PM van Nesselrooij, Marielle E van Gijn, Encarna B Gómez García, Diana M Eccles, David J Bunyan, Sapna Syngal, Elena M Stoffel, Julie O Culver, Melanie R Palomares, Tracy Graham, Lea Velsher, Janos Papp, Edith Oláh, Tsun L Chan, Suet Y Leung, Ad Geurts van Kessel, Lambertus ALM Kiemeney, Nicoline Hoogerbrugge, Marjolijn JL Ligtenberg

    Résumé Résumé Plan Plan   
• • ·Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trial

    Page :56-64

    Henry C Kitchener, Roger Blanks, Graham Dunn, Lionel Gunn, Mina Desai, Rebecca Albrow, Jean Mather, Durgesh N Rana, Heather Cubie, Catherine Moore, Rosa Legood, Alastair Gray, Sue Moss

    Résumé Résumé Plan Plan  
• • ·Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324168 participants from randomised trials

    Page :65-82

    Sripal Bangalore, Sunil Kumar, Sverre E Kjeldsen, Harikrishna Makani, Ehud Grossman, Jørn Wetterslev, Ajay K Gupta, Peter S Sever, Christian Gluud, Franz H Messerli

    Résumé Résumé Plan Plan   
• • ·Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

    Page :83-91

    Nanne K Kloosterhof, Linda BC Bralten, Hendrikus J Dubbink, Pim J French, Martin J van den Bent

    Résumé Résumé Plan Plan  
• • ·Drug interactions in childhood cancer

    Page :92-99

    Cyrine Haidar, Sima Jeha

    Résumé Résumé Plan Plan  
• • ·Treatment non-adherence in teenage and young adult patients with cancer

    Page :100-108

    Helena J Kondryn, Claire L Edmondson, Jonathan Hill, Tim OB Eden

    Résumé Résumé Plan Plan